Skip to main content
Log in

Glecaprevir/pibrentasvir

Lack of efficacy

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Lee JJ, et al. Real-world Effectiveness and Safety of Glecaprevir/Pibrentasvir in Korean patients with Chronic hepatitis C. Gut and Liver 14 (Suppl.): 92 abstr. EP-067, No. 6, Nov 2020 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Glecaprevir/pibrentasvir. Reactions Weekly 2006, 286 (2024). https://doi.org/10.1007/s40278-024-58181-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-58181-5

Navigation